NMDA receptor-mediated CaMKII/ERK activation contributes to renal fibrosis

J Zhou, S Liu, L Guo, R Wang, J Chen, J Shen - BMC nephrology, 2020 - Springer
Background This study aimed to understand the mechanistic role of N-methyl-D-aspartate
receptor (NMDAR) in acute fibrogenesis using models of in vivo ureter obstruction and in …

HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat …

B Tsogbadrakh, KD Ju, J Lee, M Han, J Koh, Y Yu… - PLoS …, 2018 - journals.plos.org
Background Renal fibrosis is characterized by excessive production and deposition of
extracellular matrix (ECM), which leads to progressive renal failure. Adenosine …

Inhibition of α1‐adrenoceptor reduces TGF‐β1‐induced epithelial‐to‐mesenchymal transition and attenuates UUO‐induced renal fibrosis in mice

H Ren, S Zuo, Y Hou, W Shang, N Liu… - The FASEB …, 2020 - Wiley Online Library
Renal fibrosis is a common pathological hallmark of chronic kidney disease (CKD). Renal
sympathetic nerve activity is elevated in patients and experimental animals with CKD and …

Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation

Y Tao, C Tang, J Wei, Y Shan, X Fang, Y Li - Molecular Medicine, 2023 - Springer
Background Renal interstitial fibrosis (RIF) is a common pathway to end-stage renal disease
regardless of the initial etiology. Currently, the molecular mechanisms for RIF remains not …

The JNK signaling pathway in renal fibrosis

K Grynberg, FY Ma, DJ Nikolic-Paterson - Frontiers in physiology, 2017 - frontiersin.org
Fibrosis of the glomerular and tubulointerstitial compartments is a common feature of chronic
kidney disease leading to end-stage renal failure. This fibrotic process involves a number of …

Glutamatergic signaling maintains the epithelial phenotype of proximal tubular cells

M Bozic, J De Rooij, E Parisi, MR Ortega… - Journal of the …, 2011 - journals.lww.com
Epithelial–mesenchymal transition (EMT) contributes to the progression of renal
tubulointerstitial fibrosis. The N-methyl-D-aspartate receptor (NMDAR), which is present in …

Naringin attenuates renal interstitial fibrosis by regulating the TGF‑β/Smad signaling pathway and inflammation

R Wang, G Wu, T Dai, Y Lang… - Experimental and …, 2021 - spandidos-publications.com
Interstitial fibrosis is a typical feature of all progressive renal diseases. The process of
fibrosis is frequently coupled with the presence of pro‑fibrotic factors and inflammation …

Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation

M Zheng, J Cai, Z Liu, S Shu, Y Wang… - Journal of cellular …, 2019 - Wiley Online Library
Renal interstitial fibrosis is a common pathological feature in progressive kidney diseases
currently lacking effective treatment. Nicotinamide (NAM), a member of water‐soluble …

Nicotinamide N‐methyltransferase ameliorates renal fibrosis by its metabolite 1‐methylnicotinamide inhibiting the TGF‐β1/Smad3 pathway

W Zhang, G Rong, J Gu, C Fan, T Guo… - The FASEB …, 2022 - Wiley Online Library
Chronic kidney disease (CKD), a disease involving damage to the kidney structure and
function, is a global public health problem. Tubulointerstitial fibrosis (TIF) is both an …

Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling

CJ Oh, JY Kim, YK Choi, HJ Kim, JY Jeong, KH Bae… - 2012 - journals.plos.org
TGF-β plays a key role in the development of renal fibrosis. Suppressing the TGF-β signaling
pathway is a possible therapeutic approach for preventing this disease, and reports have …